Clorox Company (The) (CLX) Stake Boosted by Archford Capital Strategies LLC

Archford Capital Strategies LLC boosted its position in shares of Clorox Company (The) (NYSE:CLX) by 0.5% during the first quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 8,399 shares of the company’s stock after buying an additional 43 shares during the period. Archford Capital Strategies LLC’s holdings in Clorox Company (The) were worth $1,132,000 as of its most recent filing with the SEC.

Several other large investors have also recently made changes to their positions in the stock. Bridgeworth LLC boosted its stake in shares of Clorox Company (The) by 0.3% in the first quarter. Bridgeworth LLC now owns 1,869 shares of the company’s stock worth $252,000 after buying an additional 5 shares in the last quarter. Valley National Advisers Inc. boosted its stake in shares of Clorox Company (The) by 0.6% in the first quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock worth $116,000 after buying an additional 5 shares in the last quarter. Blue Chip Partners Inc. boosted its stake in shares of Clorox Company (The) by 0.7% in the first quarter. Blue Chip Partners Inc. now owns 906 shares of the company’s stock worth $122,000 after buying an additional 6 shares in the last quarter. Wade G W & Inc. boosted its stake in shares of Clorox Company (The) by 0.3% in the first quarter. Wade G W & Inc. now owns 3,173 shares of the company’s stock worth $428,000 after buying an additional 8 shares in the last quarter. Finally, FormulaFolio Investments LLC boosted its stake in shares of Clorox Company (The) by 0.8% in the first quarter. FormulaFolio Investments LLC now owns 2,339 shares of the company’s stock worth $315,000 after buying an additional 18 shares in the last quarter. 69.83% of the stock is currently owned by institutional investors.

Shares of Clorox Company (NYSE CLX) opened at 135.57 on Tuesday. The company has a 50-day moving average of $133.48 and a 200-day moving average of $133.84. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76. The stock has a market capitalization of $17.50 billion, a P/E ratio of 25.41 and a beta of 0.40.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings data on Thursday, August 3rd. The company reported $1.53 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The business had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.65 billion. During the same quarter in the previous year, the business posted $1.30 EPS. Clorox Company (The)’s revenue for the quarter was up 2.9% on a year-over-year basis. Equities analysts expect that Clorox Company will post $5.67 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: This report was originally reported by [[site]] and is owned by of [[site]]. If you are reading this report on another website, it was stolen and reposted in violation of U.S. & international copyright and trademark legislation. The correct version of this report can be accessed at [[permalink]].

Several analysts have recently commented on CLX shares. Zacks Investment Research upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 target price for the company in a research note on Tuesday, July 4th. Vetr upgraded shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $139.67 target price for the company in a research note on Monday, April 24th. BMO Capital Markets restated a “buy” rating and issued a $136.00 target price on shares of Clorox Company (The) in a research note on Thursday, May 4th. Barclays PLC reiterated an “equal weight” rating and issued a $136.00 price objective (down previously from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. Finally, Jefferies Group LLC set a $138.00 price objective on shares of Clorox Company (The) and gave the company a “hold” rating in a research note on Wednesday, May 3rd. Two equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have given a buy rating to the stock. Clorox Company (The) presently has an average rating of “Hold” and an average target price of $129.05.

About Clorox Company (The)

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.